Metabolic engineering of non-pathogenic Escherichia coli strains for the controlled production of low molecular weight heparosan and size-specific heparosan oligosaccharides-Reference-Cited by-同舟云学术

Metabolic engineering of non-pathogenic Escherichia coli strains for the controlled production of low molecular weight heparosan and size-specific heparosan oligosaccharides

Published:2021-01 Issue:1 Volume:1865 Page:129765
ISSN:0304-4165
Container-title:Biochimica et Biophysica Acta (BBA) - General Subjects
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - General Subjects

Author:

Roy Anindita,Miyai Yuma,Rossi Alessandro,Paraswar Krishna,Desai Umesh R.,Saijoh Yukio,Kuberan Balagurunathan

Funder

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference43 articles.

1. Proteoglycans and sulfated glycosaminoglycans;Lindahl,2015

2. So you think computational approaches to understanding glycosaminoglycan-protein interactions are too dry and too rigid? Think again!;Sankaranarayanan;Curr. Opin. Struct. Biol.,2018

3. Heparan sulfate fine structure and specificity of proteoglycan functions;Nakato;Biochim. Biophys. Acta,2002

4. More to “heparin” than anticoagulation;Lindahl;Thromb. Res.,1994

5. Order out of chaos: assembly of ligand binding sites in heparan sulfate;Esko;Annu. Rev. Biochem.,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality control, safety assessment and preparation approaches of low molecular weight heparin;Carbohydrate Polymers;2024-09

2. Enzymatic construction of a library of even- and odd-numbered heparosan oligosaccharides and their N-sulfonated derivatives;International Journal of Biological Macromolecules;2024-04

3. Advancements in heparosan production through metabolic engineering andimproved fermentation;Carbohydrate Polymers;2024-01

4. Production of different molecular weight glycosaminoglycans with microbial cell factories;Enzyme and Microbial Technology;2023-12

5. Bacterial glycobiotechnology: A biosynthetic route for the production of biopharmaceutical glycans;Biotechnology Advances;2023-10